• Lilly Completes $1B Acquisition of Prevail contractpharma
    January 25, 2021
    Eli Lilly and Company has successfully completed its $1.04 billion acquisition of Prevail Therapeutics Inc., adding a new modality for drug discovery and development at Lilly, and extending research efforts through the creation of a gene therapy ...
PharmaSources Customer Service